

Leaders in Ion Channel Drug Discovery
Metrion Biosciences is a specialist ion channel contract research organisation providing drug discovery services to pharmaceutical and bioscience customers worldwide.

Metrion Biosciences
Latest News
Metrion invests in new HTS capability and expanded facilities
30 November 2022
Metrion announces the launch of its High Throughput Screening (HTS) capability, as well as the expansion of its state-of-the-art lab and office facilities. Scott Maidment has been appointed as Head of HTS to lead the new service.
Metrion and The KCNC1 Foundation collaborate on development of new ion channel modulators for ultra-rare genetic disorder
7 December 2022
Metrion and The KCNC1 Foundation, a not-for-profit organisation focused on the development of a treatment for an ultra rare genetic disorder, today announced a collaboration to progress a hit identification research project for small molecule modulators of the potassium ion channel Kv3.1, targeting KCNC1-related disorders.
Our Services
Video
Metrion Biosciences’ high throughput screening (HTS) overview
6th March 2023
Here we share a short video introducing Metrion’s expanded high throughput screening capabilities. To learn more, or to request a quote, please email info@metrionbiosciences.com
- Zeki – From Ants to Ion Channels
- Thomas’s Career So Far
- Katie – Expanding my skills to the world of ion channels
- Catherine’s Career So Far
- Yasmin – About Me
- Professor David Sheppard presents on “Cystic Fibrosis: Rescuing Faulty Channels with Targeted Therapies”

Metrion Biosciences
Upcoming Events
Research and Innovation 2023 -Accelerating Future Drug Discovery
March 29th – March 30th
Metrion will have a delegate attending the meeting and if you would like to meet with them, please email info@metrionbiosciences.com.
The 2023 ELRIG Research & Innovation conference will discuss how emerging biology and cutting-edge technologies are pioneering the medicines of tomorrow. Bringing together scientists, researchers and entrepreneurs with bold ideas to serve our shared ambitions in creating the next generation of therapeutics to cure more patients around the world. The 2023 R&I meeting will focus on cutting edge innovation, comprising the following four main sessions:
1 – Synthetic biology
2 – Healthy ageing
3 – AI driven drug discovery
4 – Ultra-rare disease drug discovery and personalized therapies
34th Medicinal Chemistry in Eastern England
April 27th
Metrion Biosciences are attending 34th Medicinal Chemistry in Eastern England, taking place on 27th April 2023 at the Fielder Centre in Hatfield, UK.
Metrion will have a delegate attending the meeting and if you would like to meet with them, please email info@metrionbiosciences.com.
Known colloquially as the “Hatfield MedChem” meeting, this is a highly successful, long-standing, one-day meeting that runs annually. The scientific program will comprise presentations showcasing medicinal chemistry case studies from tools to candidates, across a range of modalities, therapeutic areas and target classes, as well as covering more general topics at the forefront of drug discovery. The meeting aims to be informal and interactive, and is ideal for all those working in medicinal chemistry and drug discovery more widely.
Our DisPATCHes Newsletter
Receive the latest Ion Channel news and insights to your inbox
Our quarterly newsletter is packed full of the latest Ion Channel news and reviews. We cover events, webinars, research findings, and publications and insights from our team, partners, and distinguished guests. Read the latest edition here.


Let’s work together
What are your specific ion channel and assay needs?
If you have any questions or would like to discuss your specific assay requirements, we will put you directly in touch with a member of our scientific team. Contact us today to discover more.